6613:HKEXLens Technology Co. Ltd. Class H Analysis
Data as of 2026-09-02 - not real-time
HK$24.36
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Lens Technology Co., Ltd. is neutral at HKD 24.36, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 13.1%. Relative strength is 57.5 — neutral — and the MACD signal is bullish. Recent trading has carved out support near HKD 20.90 and resistance around HKD 25.32.
Multiples put this in undervalued territory: 31.2 times earnings against the sector's 35.3. Consensus targets land 35.1% above where the shares trade now. Revenue is contracting at 7.4% on a 4.9% profit margin. The 2.57% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 45.5%, a beta of 0.79 and a maximum drawdown of 50.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
Multiples put this in undervalued territory: 31.2 times earnings against the sector's 35.3. Consensus targets land 35.1% above where the shares trade now. Revenue is contracting at 7.4% on a 4.9% profit margin. The 2.57% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 45.5%, a beta of 0.79 and a maximum drawdown of 50.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 24.03
- MACD momentum is positive
- 30-day price change of +13.1%
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 31.2 versus sector average of 35.3
- Trading above the 200-day average of 24.03
- Analyst targets imply +35.1% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 31.2 versus sector average of 35.3
- Analyst targets imply +35.1% versus the current price
- Revenue contracting at -7.4%
Key Metrics & Analysis
Financial Health
Revenue Growth-7.40%
Profit Margin4.91%
P/E Ratio31.2
ROE6.81%
ROA3.34%
Debt/Equity21.50
P/B Ratio2.1
Op. Cash FlowHK$9.2B
Free Cash FlowHK$66.1M
Industry P/E35.3
Technical Analysis
TrendNeutral
RSI57.5
SupportHK$20.90
ResistanceHK$25.32
MA 20HK$23.13
MA 50HK$23.06
MA 200HK$24.03
MACDBullish
VolumeStable
Fear & Greed Index91.93
Valuation
Target PriceHK$32.90
Upside/Downside35.06%
GradeUndervalued
TypeBlend
Dividend Yield2.57%
Risk Assessment
Beta0.79
Volatility45.45%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.